Your browser doesn't support javascript.
loading
Vitiligo under anti-programmed cell death-1 therapy is associated with increased survival in melanoma patients.
Nardin, Charlée; Jeand'heur, Anne; Bouiller, Kévin; Valnet-Rabier, Marie Blanche; Dresco, Flora; Castagna, Julie; Mareschal, Adrien; Carlet, Clémentine; Nerich, Virginie; Limat, Samuel; Puzenat, Eve; Aubin, François.
Afiliação
  • Nardin C; Department of Dermatology and Inserm UMR1098, University Hospital, Besançon, France; Inserm UMR1098, Université Bourgogne Franche-Comté, Besançon, France. Electronic address: cnardin@chu-besancon.fr.
  • Jeand'heur A; Department of Dermatology and Inserm UMR1098, University Hospital, Besançon, France.
  • Bouiller K; Department of Infectious Diseases, University Hospital, Besançon, France.
  • Valnet-Rabier MB; Department of Pharmacovigilance, University Hospital, Besançon, France.
  • Dresco F; Department of Dermatology and Inserm UMR1098, University Hospital, Besançon, France.
  • Castagna J; Department of Dermatology and Inserm UMR1098, University Hospital, Besançon, France.
  • Mareschal A; Department of Dermatology and Inserm UMR1098, University Hospital, Besançon, France.
  • Carlet C; Department of Dermatology and Inserm UMR1098, University Hospital, Besançon, France.
  • Nerich V; Inserm UMR1098, Université Bourgogne Franche-Comté, Besançon, France; Department of Pharmacy, University Hospital, Besançon, France.
  • Limat S; Inserm UMR1098, Université Bourgogne Franche-Comté, Besançon, France; Department of Pharmacy, University Hospital, Besançon, France.
  • Puzenat E; Department of Dermatology and Inserm UMR1098, University Hospital, Besançon, France.
  • Aubin F; Department of Dermatology and Inserm UMR1098, University Hospital, Besançon, France. Electronic address: francois.aubin@univ-fcomte.fr.
J Am Acad Dermatol ; 82(3): 770-772, 2020 03.
Article em En | MEDLINE | ID: mdl-31734192

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Vitiligo / Toxidermias / Anticorpos Monoclonais Humanizados / Receptor de Morte Celular Programada 1 / Antineoplásicos Imunológicos / Nivolumabe / Melanoma Tipo de estudo: Observational_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Vitiligo / Toxidermias / Anticorpos Monoclonais Humanizados / Receptor de Morte Celular Programada 1 / Antineoplásicos Imunológicos / Nivolumabe / Melanoma Tipo de estudo: Observational_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article